Table 2.
Demographics and baseline characteristics
| Statistics | 97-09 M | 97-09 UK | AL0104av | AL0106ac | AL0400av | AL1009ac | Total | |
|---|---|---|---|---|---|---|---|---|
| (n = 20) | (n = 15) | (n = 93) | (n = 51) | (n = 69) | (n = 114) | (n = 362) | ||
| Age (years) | Mean (SD) | 29.4 (10.0) | 36.9 (10.4) | 15.2 (8.9) | 29.6 (8.0) | 27.6 (9.3) | 27.3 (6.6) | 25.1 (10.3) |
| Min–Max | 18.0–58.0 | 22.0–54.0 | 6.0–40.0 | 19.0–46.0 | 18.0–54.0 | 18.0–40.0 | 6.0–58.0 | |
| Gender (n [%]) | Female | 5 (25.0) | 10 (66.7) | 33 (35.5) | 24 (47.1) | 29 (42.0) | 49 (43.0) | 150 (41.4) |
| Male | 15 (75.0) | 5 (33.3) | 60 (64.5) | 27 (52.9) | 40 (58.0) | 65 (57.0) | 212 (58.6) | |
| Age group (n [%]) | <12 | 0 (0.0) | 0 (0.0) | 39 (41.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 39 (10.8) |
| 12–17 | 0 (0.0) | 0 (0.0) | 26 (28.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 26 (7.2) | |
| ≥18 | 20 (100.0) | 15 (100.0) | 28 (30.1) | 51 (100.0) | 69 (100.0) | 114 (100.0) | 297 (82.0) | |
| Smoking status (n [%]) | Smoker | 4 (20.0) | 0 (0.0) | 0 (0.0) | 5 (9.8) | 18 (26.1) | 1 (0.9) | 28 (7.7) |
| Nonsmoker | 16 (80.0) | 15 (100.0) | 93 (100.0) | 46 (90.2) | 51 (73.9) | 113 (99.1) | 334 (92.3) | |
| Asthma (n [%]) | Yes | – | – | 93 (100.0) | 26 (51.0) | 34 (49.3) | 114 (100.0) | 267 (73.8) |
| No | – | – | 0 (0.0) | 25 (49.0) | 35 (50.7) | 0 (0.0) | 60 (16.6) | |
| GINA classification (n [%]) | GINA I | – | – | 0 (0.0) | 14 (27.5) | 18 (26.1) | – | 32 (8.8) |
| GINA II | – | – | 76 (81.7) | 12 (23.5) | 16 (23.2) | – | 104 (28.7) | |
| GINA III | – | – | 17 (18.3) | 0 (0.0) | 0 (0.0) | – | 17 (4.7) | |
| GINA IV | – | – | 0 (0.0) | 0 (0.0) | 0 (0.0) | – | 0 (0.0) | |
| No asthma | – | – | 0 (0.0) | 25 (49.0) | 35 (50.7) | – | 60 (16.6) | |
| FEV1 or PEF (% of predicted value) |
n | – | – | 93 | 51 | 69 | 61 | 274 |
| Mean (SD) | – | – | 93.1 (10.6) | 101.8 (15.2) | 104.2 (14.2) | 98.7 (9.8) | 98.8 (13.1) | |
| Min–Max | – | – | 80.0–139.0 | 80.1–135.7 | 75.0–147.0 | 82.2–123.8 | 75.0–147.0 | |
| Duration of allergic rhinoconjunctivitis (years) | n | 20 | 15 | 77 | 51 | 69 | 114 | 346 |
| Mean (SD) | 5.8 (3.2) | 21.1 (10.1) | 5.7 (5.1) | 12.5 (8.6) | 8.6 (7.8) | 8.2 (5.8) | 8.8 (7.4) | |
| Min–Max | 2.0–13.0 | 2.0–40.0 | 1.0–20.0 | 2.0–39.0 | 1.0–45.0 | 0.0–24.0 | 0.0–45.0 |
GINA Global Initiative for Asthma, FEV1 Forced Expiratory Flow in 1 sec, PEF Peak Expiratory Flow